Literature DB >> 31238163

Telemedicine for Allergy Services to Rural Communities.

Luisa Taylor1, Morgan Waller1, Jay M Portnoy2.   

Abstract

Telemedicine (TM) involves the use of technology to provide medical services to patients who live at a distance. It can be used asynchronously for interpretation of test results (spirometry, skin tests imaging studies), and for communication of information when the simultaneous presence of provider and patient is unnecessary. Synchronous encounters can either be unscheduled and initiated on demand by patients or be facilitated substitutes for in-person visits. The latter results in asthma outcomes that are as good as those for in-person visits while reducing the cost and inconvenience of travel from rural communities to urban centers. Facilitated visits can be done in the ambulatory and emergency department settings, and they can be used for inpatient consults when allergy specialists are not readily available. Both patients and providers experience high degrees of satisfaction with this type of visit. In addition, virtual visits performed using TM are cost-effective. TM offers a solution to the shortage of specialty care that is present in rural communities.
Copyright © 2019 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Direct-to-consumer; Facilitated visits; Synchronous visits; Telemedicine

Year:  2019        PMID: 31238163     DOI: 10.1016/j.jaip.2019.06.012

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


  10 in total

Review 1.  The applications of eHealth technologies in the management of asthma and allergic diseases.

Authors:  Alberto Alvarez-Perea; Ves Dimov; Florin-Dan Popescu; José Manuel Zubeldia
Journal:  Clin Transl Allergy       Date:  2021-09-06       Impact factor: 5.657

Review 2.  Achieving the Quadruple Aim to deliver value-based allergy care in an ever-evolving health care system.

Authors:  Edward G A Iglesia; Matthew Greenhawt; Marcus S Shaker
Journal:  Ann Allergy Asthma Immunol       Date:  2020-04-11       Impact factor: 6.347

3.  A Provider-Facing eHealth Tool for Transitioning Youth With Special Health Care Needs From Pediatric to Adult Care: Mixed Methods, User-Engaged Usability Study.

Authors:  Darcy Jones McMaughan; Sherry Lin; Jennifer Ozmetin; Judith Gayle Beverly; Joshua Brog; Emily Naiser
Journal:  JMIR Form Res       Date:  2021-05-25

Review 4.  Scribes, EHRs, and Workflow Efficiencies in Allergy Practices.

Authors:  Annette F Carlisle; Saul M Greenbaum; Mike S Tankersley
Journal:  Curr Allergy Asthma Rep       Date:  2020-07-09       Impact factor: 4.806

5.  Evaluating the Quality of Asynchronous Versus Synchronous Virtual Care in Patients With Erectile Dysfunction: Retrospective Cohort Study.

Authors:  Lauren Broffman; Melynda Barnes; Kevin Stern; Amy Westergren
Journal:  JMIR Form Res       Date:  2022-01-13

6.  Characterizing telemedicine use in clinical immunology and allergy in Canada before the COVID-19 pandemic.

Authors:  Erika Yue Lee; Christine Song; Peter Vadas; Matthew Morgan; Stephen Betschel
Journal:  Allergy Asthma Clin Immunol       Date:  2021-12-13       Impact factor: 3.406

Review 7.  Telehealth and Allergy Services in Rural and Regional Locations That Lack Specialty Services.

Authors:  Kirk H Waibel; Tamara T Perry
Journal:  J Allergy Clin Immunol Pract       Date:  2022-06-29

8.  Synchronous Telemedicine in Allergy: Lessons Learned and Transformation of Care During the COVID-19 Pandemic.

Authors:  Iason Thomas; Leonard Q C Siew; Krzysztof Rutkowski
Journal:  J Allergy Clin Immunol Pract       Date:  2020-10-19

Review 9.  A Review of Patient and Provider Satisfaction with Telemedicine.

Authors:  Mary Nguyen; Morgan Waller; Aarti Pandya; Jay Portnoy
Journal:  Curr Allergy Asthma Rep       Date:  2020-09-22       Impact factor: 4.806

10.  COVID-19 pandemic: Practical considerations on the organization of an allergy clinic-An EAACI/ARIA Position Paper.

Authors:  Oliver Pfaar; Ludger Klimek; Marek Jutel; Cezmi A Akdis; Jean Bousquet; Heimo Breiteneder; Sharon Chinthrajah; Zuzana Diamant; Thomas Eiwegger; Wytske J Fokkens; Hans-Walter Fritsch; Kari C Nadeau; Robyn E O'Hehir; Liam O'Mahony; Winfried Rief; Vanitha Sampath; Manfred Schedlowski; María José Torres; Claudia Traidl-Hoffmann; De Yun Wang; Luo Zhang; Matteo Bonini; Randolf Brehler; Helen Annaruth Brough; Tomás Chivato; Stefano R Del Giacco; Stephanie Dramburg; Radoslaw Gawlik; Aslı Gelincik; Karin Hoffmann-Sommergruber; Valerie Hox; Edward F Knol; Antti Lauerma; Paolo M Matricardi; Charlotte G Mortz; Markus Ollert; Oscar Palomares; Carmen Riggioni; Jürgen Schwarze; Isabel Skypala; Eva Untersmayr; Jolanta Walusiak-Skorupa; Ignacio J Ansotegui; Claus Bachert; Anna Bedbrook; Sinthia Bosnic-Anticevich; Luisa Brussino; Giorgio Walter Canonica; Victoria Cardona; Pedro Carreiro-Martins; Alvaro A Cruz; Wienczyslawa Czarlewski; João A Fonseca; Maia Gotua; Tari Haahtela; Juan Carlos Ivancevich; Piotr Kuna; Violeta Kvedariene; Désirée Erlinda Larenas-Linnemann; Amir Hamzah Abdul Latiff; Mika Mäkelä; Mário Morais-Almeida; Joaquim Mullol; Robert Naclerio; Ken Ohta; Yoshitaka Okamoto; Gabrielle L Onorato; Nikolaos G Papadopoulos; Vincenzo Patella; Frederico S Regateiro; Bolesław Samoliński; Charlotte Suppli Ulrik; Sanna Toppila-Salmi; Arunas Valiulis; Maria-Teresa Ventura; Arzu Yorgancioglu; Torsten Zuberbier; Ioana Agache
Journal:  Allergy       Date:  2021-03       Impact factor: 14.710

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.